Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Copanlisib in Relapsed/Refractory DLBCL
NCT02391116Phase 2Completed
- Sponsor
- Bayer
- Start
- May 2015
- Primary completion
- Jul 2016
- Modality
- Small Molecules
- Countries
- 10
01
Overview
A Phase 2 trial of copanlisib in diffuse large B-cell lymphoma (DLBCL), sponsored by Bayer. Started May 2015; status: completed.
02
Drugs
copanlisib
03
Conditions
diffuse large B-cell lymphoma (DLBCL)
Beyond the preview
Go deeper on NCT02391116.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02391116.